Medication-info.com Search Menu

Rolvedon (Eflapegrastim): Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx)
Strength:
13.2 mg/0.6 mL
Active ingredient:
Similar drugs:

Patient information: uses, side effects, how to take - Rolvedon

What is Rolvedon?

Rolvedon is a man-made form of granulocyte colony-stimulating factor (G-CSF). G-CSF is a substance produced by the body. It stimulates the growth of neutrophils, a type of white blood cell important in the body’s fight against infection.

It is not known if Rolvedon is safe and effective in children.

Do not take Rolvedon if you have had a serious allergic reaction to eflapegrastim, pegfilgrastim or filgrastim products.

Before receiving Rolvedon, tell your healthcare provider about all of your medical conditions, including if you:

  • have a sickle cell disorder
  • have kidney problems
  • are pregnant or plan to become pregnant. It is not known if Rolvedon can harm your unborn baby. Tell your healthcare provider right away if you become pregnant during treatment with Rolvedon.

  • are breastfeeding or plan to breastfeed. It is not known if Rolvedon passes into your breast milk.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

How will I receive Rolvedon?

  • Rolvedon is given as an injection under your skin (subcutaneous injection) by a healthcare provider. If your healthcare provider decides that the subcutaneous injections can be given at home by you or your caregiver, follow the detailed “Instructions for Use” that comes with your Rolvedon for information on how to prepare and inject a dose of Rolvedon.
  • You and your caregiver will be shown how to prepare and inject Rolvedon before you use it.
  • You will receive 1 injection of Rolvedon for each cycle of chemotherapy.
  • You will receive your injection of Rolvedon about 24 hours after you finish receiving your chemotherapy.
  • You should not receive Rolvedon for 14 days before or within 24 hours after your dose of chemotherapy.
  • If you miss a dose of Rolvedon, talk to your healthcare provider about when you should receive your next dose.

What are the possible side effects of Rolvedon?

Rolvedon may cause serious side effects, including:

  • Spleen rupture. Your spleen may become enlarged and can rupture. A ruptured spleen can cause death. Call your healthcare provider right away if you have pain in the left upper stomach-area or your left shoulder.
  • A serious lung problem called Acute Respiratory Distress Syndrome (ARDS). Call your healthcare provider or get emergency help right away if you have shortness of breath with or without a fever, trouble breathing, or a fast rate of breathing.
  • Serious allergic reactions. Rolvedon can cause serious allergic reactions. These reactions can cause a rash all over your whole body, shortness of breath, wheezing, dizziness, swelling around your mouth or eyes, fast heart rate, and sweating. If you have any of these symptoms, stop using Rolvedon and call your healthcare provider or get emergency medical help right away.
  • Sickle cell crises. You may have a serious sickle cell crisis, which could lead to death, if you have a sickle cell disorder and receive Rolvedon. Call your healthcare provider right away if you develop symptoms of sickle cell crisis such as pain or difficulty breathing.
  • Kidney injury (glomerulonephritis). Rolvedon can cause kidney injury. Call your healthcare provider right away if you develop any of the following symptoms:
  • swelling of your face or ankles
  • blood in your urine or dark colored urine
  • you urinate less than usual
  • Increased white blood cell count (leukocytosis). Your healthcare provider will check your blood count during treatment with Rolvedon.
  • Decreased platelet count (thrombocytopenia). Your healthcare provider will check your blood during treatment with Rolvedon. Tell your healthcare provider if you have unusual bleeding or bruising during treatment with Rolvedon. This could be a sign of decreased platelet counts, which may reduce the ability of your blood to clot.
  • Capillary Leak Syndrome. Rolvedon can cause fluid to leak from blood vessels into your body’s tissues. This condition is called “Capillary Leak Syndrome” (CLS). CLS can quickly cause you to have symptoms that may become life-threatening. Get emergency help right away if you develop any of the following symptoms:
  • swelling or puffiness and are urinating less than usual
  • trouble breathing
  • swelling of your stomach area (abdomen) and feeling of fullness
  • dizziness or feeling faint
  • a general feeling of tiredness
  • Myelodysplastic syndrome and acute myeloid leukemia. If you have breast cancer or lung cancer, when Rolvedon is used with chemotherapy and radiation therapy, or with radiation therapy alone, you may have an increased risk of developing a precancerous blood condition called myelodysplastic syndrome (MDS) or a blood cancer called acute myeloid leukemia (AML). Symptoms of MDS and AML may include tiredness, fever, and easy bruising or bleeding. Call your healthcare provider if you develop these symptoms during treatment with Rolvedon.
  • Inflammation of the aorta (aortitis). Inflammation of the aorta (the large blood vessel which transports blood from the heart to the body) has been reported in patients who received pegfilgrastim products. Symptoms may include fever, abdominal pain, feeling tired, and back pain. Call your healthcare provider if you experience these symptoms.

The most common side effects of Rolvedon include:

  • tiredness
  • nausea
  • diarrhea
  • bone pain
  • headache
  • fever
  • decreased red blood cell count
  • rash
  • muscle and joint pain
  • back pain

These are not all the possible side effects of Rolvedon.

Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

How should I store Rolvedon?

  • Store Rolvedon in the refrigerator between 36°F to 46°F (2°C to 8°C).
  • Do not freeze Rolvedon. Throw away (dispose of) any Rolvedon that has been frozen.
  • Store Rolvedon in the original carton to protect from light.
  • Do not shake Rolvedon.
  • Take the carton out of the refrigerator and place the sealed blister tray on a clean flat surface for at least 30 minutes to allow it to reach room temperature before use.
  • Throw away (dispose of) any prefilled syringe of Rolvedon that has been left at room temperature, 68ºF to 77ºF (20ºC to 25ºC), for more than 72 hours.

Keep Rolvedon and all medicines out of the reach of children.

General information about the safe and effective use of Rolvedon.

Medicines are sometimes prescribed for purposes other than those listed in a Patient Information leaflet. Do not use Rolvedon for a condition for which it was not prescribed. Do not give Rolvedon to other people, even if they have the same symptom that you have. It may harm them. You can ask your pharmacist or healthcare provider for information about Rolvedon that is written for health professionals.

What are the ingredients in Rolvedon?

Active ingredient: eflapegrastim-xnst

Inactive ingredients: citric acid monohydrate, mannitol, polysorbate 80, and sodium chloride in Water for Injection. Sodium hydroxide may be used to adjust pH to 5.5 during manufacturing.

Manufactured by: Assertio Specialty Pharmaceuticals, LLC, Lake Forest, IL 60045

U.S. License No. 2428

For more information, go to www.rolvedon.com or call 1-800-518-1084.

This Patient Information has been approved by the U.S. Food and Drug Administration.

Revised: 02/2026

INSTRUCTIONS FOR USE

ROLVEDON ® [roll veh don]

(eflapegrastim-xnst)

injection, for subcutaneous use

Single-Dose Prefilled Syringe

This Instructions for Use contains information on how to inject Rolvedon. Read this Instructions for Use before using Rolvedon and each time you get a refill. There may be new information. This information does not take the place of talking to your healthcare provider about your medical condition or treatment.
Important Information You Need To Know Before Injecting Rolvedon
  • It is important that you do not try to give the injection unless you or your caregiver have received training from your healthcare provider.
  • Rolvedon is for use under the skin (subcutaneous injection) only.
  • To help reduce needle stick injuries, each prefilled syringe has a needle guard that is automatically activated to cover the needle after the injection is complete.
  • Make sure the name Rolvedon appears on the carton and prefilled syringe label.
  • Do not use a Rolvedon prefilled syringe after the expiration date on the label.
  • Do not use the Rolvedon prefilled syringe if it has been dropped on a hard surface. The prefilled syringe may be broken even if you cannot see the break. Use a new prefilled syringe.
  • Do not use the Rolvedon prefilled syringe if the seal on the carton or the seal on the blister tray is broken.
  • Do not shake the Rolvedon prefilled syringe.
  • Do not touch the needle guard clips before use. Touching them may cause the needle guard to be activated too early.
  • Do not remove the needle cap until just before you give the injection.
Rolvedon prefilled syringe parts

Figure A

Storing the Rolvedon prefilled syringe
  • Store Rolvedon in the refrigerator between 36°F to 46°F (2°C to 8°C).
  • Do not freeze Rolvedon. Throw away (dispose of) any Rolvedon that has been frozen.
  • Store Rolvedon in the original carton to protect from light.
  • Take the carton out of the refrigerator and place the sealed blister tray on a clean flat surface for at least 30 minutes to allow it to reach room temperature before use.
  • Throw away (dispose of) any prefilled syringe of Rolvedon that has been left at room temperature, 68ºF to 77ºF (20ºC to 25ºC), for more than 72 hours.

Keep Rolvedon and all medicines out of the reach of children.

Preparing to inject Rolvedon
Step 1. Remove the carton from refrigerator
  • Remove the carton from the refrigerator (see Figure B).
  • Check the expiration date on the carton (see Figure C).

Do not use the prefilled syringe if it is expired or if the carton has been previously opened.

  • Open the carton and remove the blister tray.

Figure B

Figure C

Step 2. Allow Rolvedon to reach room temperature
Place the sealed blister tray on a clean flat surface and wait 30 minutes to reach room temperature (see Figure D). Do not warm up the prefilled syringe in any other way.

Figure D

Step 3. Gather the supplies needed for your injection

Gather the following supplies for the injection (see Figure E):

  • 1 sterile cotton ball or gauze pad
  • 1 alcohol wipe
  • 1 sharps disposal container. See “Disposing of used Rolvedon prefilled syringes” at the end of this Instructions for Use.

Figure E

Step 4. Wash your hands
Wash your hands with soap and water.
Step 5. Remove the prefilled syringe from the blister tray
  • Open the tray by peeling away the tray cover.
  • To remove the prefilled syringe, grip the prefilled syringe by the center of the viewing window as shown in Figure F.
  • Do not remove the prefilled syringe by the plunger rod, plunger head, or the needle cap.
  • Do not touch the needle guard clips, as it could activate the needle guard.
  • Do not remove the needle cap until you are ready to inject.

Figure F

Step 6. Inspect the prefilled syringe and medicine
  • Visually inspect the prefilled syringe. Do not use the prefilled syringe if it appears damaged (for example, if the syringe is cracked or broken, or if the plunger rod is detached or broken) or if the needle cap is missing.
  • Check the expiration date on the prefilled syringe label. Do not use if the expiration date has passed.
  • Check the medicine inside the prefilled syringe through the viewing window (see Figure G). The medicine inside should be clear and colorless. It is normal to see small air bubbles in the medicine. It does not need to be removed.
  • Do not use the prefilled syringe if:
  • the medicine appears discolored or cloudy.
  • the medicine contains lumps, flakes, or particles.

Figure G

Step 7. Select the injection site

Figure H

•The recommended injection sites for a subcutaneous injection are the (see Figure H):

  • Abdomen (except for a two-inch area surrounding the navel)
  • Upper outer thighoOuter upper arm (only if someone else is giving you the injection)
  • Upper outer buttock (only if someone else is giving you the injection)
  • Do not inject into area of the skin that is tender, damaged, bruised, scarred or hard.
  • Do not inject into moles, scars, birthmarks or stretchmarks.
  • If you want to use the same injection site, make sure it is not the same spot on the injection site you used for a previous injection.
Step 8. Clean the injection site
  • Clean the injection site with an alcohol wipe (see Figure I). • Allow the area of skin to dry before injecting.

Do not touch or blow on the cleaned area before injecting.

Figure I

Injecting Rolvedon
Step 9. Remove needle cap
  • Do not remove the needle cap until you are ready to inject. When ready for the injection, carefully remove the needle cap by pulling it straight off (see Figure J).
  • When removing the needle cap, hold the prefilled syringe as shown in Figure J.
  • Throw away (dispose of) the needle cap in the sharps disposal container.
  • Do not put the needle cap back onto the prefilled syringe after it has been removed. This can damage the needle and cause needle stick injuries.
  • Do not hold the prefilled syringe by the plunger rod or touch the needle guard clips when removing the needle cap.

Figure J

Step 10. Insert the needle
  • Hold the prefilled syringe at a 45 to 90-degree angle (see Figure K).
  • Using your other hand, gently pinch the cleaned injection site as shown in Figure K.
  • Fully insert the needle into the skin in a quick “dart-like” motion.

Do not touch the plunger head while inserting the needle into the skin.

Figure K

Step 11. Inject Rolvedon
  • Release the pinched skin.
  • Hold the prefilled syringe as shown in Figure L with your thumb on the plunger head ready to inject.
  • Slowly press the plunger head down to inject the medicine.
  • Hold the syringe steadily in place while the needle is inserted.

Note: You may feel some resistance, this is normal.

Figure L

  • Push the plunger head down until it reaches the bottom to make sure all of the medicine is injected (see Figure M).
  • You may hear a click when the plunger head reaches the bottom.

Figure M

Step 12. Activate the needle guard
  • Gently lift your thumb to release the plunger until the entire needle is covered by the needle guard. Then remove the prefilled syringe from the injection site at the same angle as inserted as shown in Figure N.
  • If there is bleeding, lightly press a cotton ball or gauze on the injection site.

Figure N

Disposing of used Rolvedon prefilled syringes
  • Put the used prefilled syringe and needle cap in an FDA-cleared sharps disposal container right away after use (see Figure O). Do not throw away (dispose of) the prefilled syringe in your household trash.
  • If you do not have an FDA-cleared sharps disposal container, you may use a household container that is:
  • made of a heavy-duty plastic,
  • can be closed with a tight-fitting, puncture-resistant lid, without sharps being able to come out,
  • upright and stable during use,
  • leak-resistant, and
  • properly labeled to warn of hazardous waste inside the container.
  • When your sharps disposal container is almost full, you will need to follow your community guidelines for the right way to dispose of your sharps disposal container. There may be state or local laws about how you should throw away used needles and syringes. For more information about safe sharps disposal, and for specific information about sharps disposal in the state that you live in, go to the FDA’s website at: http://www.fda.gov/safesharpsdisposal.
  • Do not reuse the prefilled syringes or throw them into household waste.
  • Do not recycle prefilled syringes or sharps disposal container.
  • Do notattempt to remove the needle from the prefilled syringe.

Important: Keep the sharps disposal container out of the reach of children.

Figure O

Manufactured by: Assertio Specialty Pharmaceuticals, LLC Lake Forest, IL 60045

U.S. License No. 2428

For more information, go to www.rolvedon.com or call 1-800-518-1084.

This Instructions for Use has been approved by the U.S. Food and Drug Administration. Issued: 02/2026

About this document

Source: FDA drug labeling via NLM DailyMed · Application number: BLA 761148 · View the label on DailyMed

Revision date stated in the text: February 2026

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Rolvedon

Rx or OTC
Prescription (Rx)?
  • This drug is available only with a prescription from a licensed healthcare provider.
  • Rx
Drug class Leukocyte Growth Factor
Active ingredient Eflapegrastim 13.2 mg/0.6 mL
Dosage form Injection, solution
Route Subcutaneous
Marketing status listed in the FDA NDC Directory
Company (applicant) SPECTRUM PHARMS
FDA approval BLA 761148Biologics License Application (BLA) Approved September 9, 2022
Manufacturers 2 labelers list this drug on DailyMed
Packages (NDC)
Package
13.2 mg/0.6 mL – 0.6 ml in 1 syringe, glass NDC 82497-132-01

Source: FDA drug labeling via NLM DailyMed, data as of October 31, 2026. FDA data (DailyMed, Orange Book, Drug Shortages, enforcement reports). Not a substitute for the advice of a doctor or pharmacist.